
Cat. #158341
NBQ-48-3-234 TOM small molecule
Cat. #: 158341
Sub-type: Inhibitor
Availability: Please enquire for quantities and pricing
Application: cell hypoxia marker
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Osvaldo Cox (Retired), Beatriz Zayas
Institute: Universidad Ana G. Mendez
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: NBQ-48-3-234 TOM small molecule
- Research fields: Cancer;Cell signaling and signal transduction;Drug development
- Tool sub type: Inhibitor
- Description: Inhibitor of growth in several cancer cell line models. This small molecule can also be used as a cell hypoxia marker.
- Application: cell hypoxia marker
- Iupac: 3-nitro-7 (2,3,4-trimethoxy-benzyl)-benzimidazo[3,2-a]quinoliniun chloride
Handling
- Shipping conditions: Dry Ice
Application Details
- Application: cell hypoxia marker
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)




